Annual Earl W. Davie Symposium (2013)

Morning Session
1. Introduction
2. “The origin of reversible protein phosphorylation as a regulatory mechanism”
3. “Hemostasis and thrombosis, new questions raised from mouse models”
4. “Direct and indirect immunocamouflage of blood antigens”
5. “High-fidelity SELEXion: an improved platform for discovery of aptamer-based therapeutics”
6. “From the rivers of Babylon to the coronary bloodstream: The αIIbβ3 Story”
7. “Shot-gun”talks

Afternoon Session
1. “Diverse properties of polyphosphates in the blood”
2. “Flipping and flopping and blocking platelet procoagulant phosphatidylserine”
3. “Developmental hemostasis: Neonatal platelets acting their age”
4. “Clotting the unclottable: halting severe hemorrhaging, and clotting without fibrinogen”
5. “Protease activated receptors – a 3-dimensional view”
6. Closing remarks

Part 1:

0:00:00 – 0:06:00 | Dr. Ed Conway, Opening Remarks

0:06:02 – 0:58:00 | Dr. Edmond Fischer “The origin of reversible protein phosphorylation as a regulatory mechanism”

0:58:05 – 1:35:50  Dr. David Motto “Hemostasis and thrombosis, new questions raised from mouse models”

1:36:03  – 1:48:40 | Dana Kyluik-Price “Direct and indirect immunocamouflage of blood antigens”

1:49:00- 2:09:05 | Eric Ouellett “High-fidelity SELEXion: an improved platform for discovery of aptamer-based therapeutics”

Part 2:

0:00:00 – 0:59:50 | Barry Coller “From the rivers of Babylon to the coronary bloodstream: The αIIbβ3 Story”

0:59:54 – 1:19:36 | Shot-gun talks

Part 3:

0:01:20 – 0:19:33 | Jonathan Foley “Diverse properties of polyphosphates in the blood”

0:19:44 – 0:56:28 | Margaret Rand “Flipping and flopping and blocking platelet procoagulant phosphatidylserine”

0:56:30  – 1:33:38 | Sara Israels “Developmental hemostasis: Neonatal platelets acting their age”

Part 4:

0:01:20 – 0:24:10 | Christian Kastrup “Clotting the unclottable: halting severe hemorrhaging, and clotting without fibrinogen”

0:24:23 – 1:33:34 | Shaun Coughlin “Protease activated receptors – a 3-dimensional view”

1:33:36 – 1:41:15 |Closing remarks